Arbor Investment Advisors LLC Has $491,000 Stake in Johnson & Johnson (NYSE:JNJ)

Arbor Investment Advisors LLC is an investment firm based in Chicago, Illinois, that manages over $25 billion in assets for its clients. The firm was founded in 1990 and provides a range of investment services, including equity, fixed income, and alternative investment strategies.

As of the last available filing with the Securities and Exchange Commission (SEC), which was on December 31, 2020, Arbor Investment Advisors LLC reported holding a stake of approximately $491,000 in Johnson & Johnson (NYSE: JNJ). Johnson & Johnson is a multinational corporation that operates in the healthcare sector, with its products and services ranging from pharmaceuticals and medical devices to consumer health products.

The investment in Johnson & Johnson represents a small portion of Arbor's overall portfolio, but it reflects the firm's confidence in the long-term growth potential of the healthcare industry and the specific strengths of Johnson & Johnson as a company. The investment may also be influenced by various factors such as the company's financial performance, competitive positioning, and regulatory environment.

Johnson & Johnson reported strong financial results for 2020, with revenue of $82.6 billion and earnings per share of $6.57. The company's pharmaceuticals segment, which includes blockbuster drugs such as Remicade and Stelara, accounted for the largest share of revenue at $36.5 billion. The consumer health segment, which includes brands such as Tylenol and Listerine, generated revenue of $15.2 billion. The medical devices segment, which includes products such as hip and knee replacements and surgical instruments, reported revenue of $12.7 billion.

Despite facing challenges related to product recalls and regulatory investigations in the past, Johnson & Johnson has a strong brand reputation and a diverse portfolio of products and services that position it well for long-term growth. The company's focus on research and development, as well as its global reach, also give it a competitive edge in the healthcare industry.

In summary, Arbor Investment Advisors LLC's stake in Johnson & Johnson reflects the firm's belief in the long-term growth potential of the healthcare industry and the specific strengths of Johnson & Johnson as a company. The investment represents a small portion of Arbor's overall portfolio but is significant given the size and influence of Johnson & Johnson in the healthcare sector.